Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease.

Koji Sawada, Dis Colon Rectum. 2003 Oct;46(10 Suppl):S66-77.

 Clinical data suggest that leukocytapheresis might be an effective adjunct to therapy for inflammatory bowel disease to promote remission, taper conventional drug dosage, and potentially reduce the number of patients who require colectomy. The results should further understanding of the pathophysiology of inflammatory bowel disease.

https://pubmed.ncbi.nlm.nih.gov/14530661/